-
In this newsletter, we discuss legal news which affects the pharmaceutical and pharmacy sector. The Commission’s proposal on the Critical Medicines Act will hopefully provide tools for member states to avoid supply chain issues in relation to critical medicines. Interpretations by the Court of Justice of the European Union assist market players to navigate in […]
-
In this newsletter, we hope to draw your attention to legal news that, in one way or another, affects innovations in the life sciences and healthcare sector. Whether this relates to the early stages of product development (the Biotech and Biomanufacturing Hub) or questions related to the use of innovative products (the AI Act), innovation […]
-
The year has passed in the blink of an eye. We’ll skip the recap and instead start looking forward to 2025 already. Next year will bring us many interesting but also challenging legal developments in the life sciences and healthcare sector. We will hereby give you a short overview of the upcoming changes. The Health Technology […]
-
In this month’s newsletter we bring you a short overview of hot topics in the Life Sciences and Healthcare sector in the Baltics. Some of these topics were also discussed during our regional webinar on 12 September. Video of the webinar is available here. Compulsory liability insurance for healthcare providers in Estonia The new Compulsory […]
-
This month’s Life Sciences & Healthcare newsletter bring you a short overview of how off-label use of medicinal products is regulated in the Baltics. This is especially interesting in the light of the recent judgement of the European Court of Justice on off-label use of medicinal products. Risk-benefit balance includes risks resulting from off-label use The […]
